KEVZARA (sarilumab) is an injectable prescription medicine called an interleukin-6 (IL-6) receptor blocker. KEVZARA is used to treat adult patients with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease-modifying antirheumatic drug (DMARD) has been used and did not work well or could not be tolerated.

KEVZARA comes in a prefilled syringe. Its recommended use is once every 2 weeks. It may be used on its own, or in combination with other conventional DMARDs like methotrexate (MTX).